primary antibody against il-33 (GeneTex)
90
Structured Review
GeneTex
primary antibody against il-33
Primary Antibody Against Il 33, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il-33/antibodies+against+il+33/pm37403020-69-25-29
Average 90 stars, based on 1 article reviews
Primary Antibody Against Il 33, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il-33/antibodies+against+il+33/pm37403020-69-25-29
Average 90 stars, based on 1 article reviews
primary antibody against il-33 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Activity Assay:Article Title: IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition. Article Snippet: After deparaffinization and quenching the endogenous peroxidase activity with 0.3% H2O2, the section was blocked with the non-immune serum, followed by incubation with the primary Article Title: IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition Article Snippet: After deparaffinization and quenching the endogenous peroxidase activity with 0.3% H 2 O 2, the section was blocked with the non-immune serum, followed by incubation with the primary Article Title: Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach Article Snippet: Incubation with the primary Incubation:Article Title: IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition. Article Snippet: After deparaffinization and quenching the endogenous peroxidase activity with 0.3% H2O2, the section was blocked with the non-immune serum, followed by incubation with the primary Article Title: IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition Article Snippet: After deparaffinization and quenching the endogenous peroxidase activity with 0.3% H 2 O 2, the section was blocked with the non-immune serum, followed by incubation with the primary Article Title: Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach Article Snippet: Incubation with the primary Negative Control:Article Title: IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition. Article Snippet: After deparaffinization and quenching the endogenous peroxidase activity with 0.3% H2O2, the section was blocked with the non-immune serum, followed by incubation with the primary Article Title: IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition Article Snippet: After deparaffinization and quenching the endogenous peroxidase activity with 0.3% H 2 O 2, the section was blocked with the non-immune serum, followed by incubation with the primary Article Title: Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach Article Snippet: Incubation with the primary Control:Article Title: IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition. Article Snippet: After deparaffinization and quenching the endogenous peroxidase activity with 0.3% H2O2, the section was blocked with the non-immune serum, followed by incubation with the primary Article Title: IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition Article Snippet: After deparaffinization and quenching the endogenous peroxidase activity with 0.3% H 2 O 2, the section was blocked with the non-immune serum, followed by incubation with the primary Article Title: Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach Article Snippet: Incubation with the primary |
